Literature DB >> 9293130

Acute dentoalveolar infections: an investigation of the duration of antibiotic therapy.

M V Martin1, L P Longman, J B Hill, P Hardy.   

Abstract

OBJECTIVE: To evaluate shortened courses of antibiotics in the management of dentoalveolar abscesses.
DESIGN: Prospective clinical study over a 3-year period.
SETTING: Examinations department of the Liverpool University Dental Hospital.
SUBJECTS: 759 patients, with acute dentoalveolar abscesses associated with swelling, and an elevation of axillary temperature to above 38.5 degrees C, were included in the investigation. The minimum age of the patients was 16 years.
INTERVENTIONS: The initial treatment was to drain the abscess by incision (124 patients), or extraction (635). The patients were prescribed amoxycillin (250 mg every 8 hours), clindamycin (150 mg every 6 hours) or erythromycin stearate (250 mg every 6 hours) and instructed to drink plenty of fluid. All the patients were seen 2 or 3 and 10 days later; only patients who were seen at these times were included in the trial. MAIN OUTCOME MEASURES: Resolution of the swelling and a normal axillary temperature.
RESULTS: At first review 748 patients (98.6%) had normal temperatures, marked resolution of the swelling and the antibiotic was discontinued. None of these 748 patients required further antibiotic therapy.
CONCLUSIONS: The duration of antibiotic therapy in most patients with acute dentoalveolar infections can safely be 2-3 days, provided that drainage has been established. It is not, therefore, necessary for the majority of patients to complete a 5-day course of antibiotics.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9293130     DOI: 10.1038/sj.bdj.4809444

Source DB:  PubMed          Journal:  Br Dent J        ISSN: 0007-0610            Impact factor:   1.626


  9 in total

1.  'Antibiotics advice is nothing new' says FGDP (UK).

Authors: 
Journal:  Br Dent J       Date:  2017-09-08       Impact factor: 1.626

2.  Antibiotic prescribing practices by dentists: a review.

Authors:  Najla Saeed Dar-Odeh; Osama Abdalla Abu-Hammad; Mahmoud Khaled Al-Omiri; Ameen Sameh Khraisat; Asem Ata Shehabi
Journal:  Ther Clin Risk Manag       Date:  2010-07-21       Impact factor: 2.423

3.  Antimicrobial prescribing by dentists in Wales, UK: findings of the first cycle of a clinical audit.

Authors:  A L Cope; E Barnes; E P Howells; A M Rockey; A J Karki; M J Wilson; M A O Lewis; J G Cowpe
Journal:  Br Dent J       Date:  2016-07-08       Impact factor: 1.626

4.  Oral antibiotic prescribing by NHS dentists in England 2010-2017.

Authors:  Martin H Thornhill; Mark J Dayer; Michael J Durkin; Peter B Lockhart; Larry M Baddour
Journal:  Br Dent J       Date:  2019-12       Impact factor: 1.626

5.  Dental Students' Knowledge and Attitudes towards Antibiotic Prescribing Guidelines in Riyadh, Saudi Arabia.

Authors:  Abdulrahman AboAlSamh; Abdulmalik Alhussain; Nawaf Alanazi; Rakan Alahmari; Naila Shaheen; Abdallah Adlan
Journal:  Pharmacy (Basel)       Date:  2018-05-07

Review 6.  Antibiotic abuse during endodontic treatment: A contributing factor to antibiotic resistance.

Authors:  Ramta Bansal; Aditya Jain; Mehak Goyal; Tejveer Singh; Himanshu Sood; Harjeet Singh Malviya
Journal:  J Family Med Prim Care       Date:  2019-11-15

Review 7.  Oral Antibiotic for Empirical Management of Acute Dentoalveolar Infections-A Systematic Review.

Authors:  Leanne Teoh; Monique C Cheung; Stuart Dashper; Rodney James; Michael J McCullough
Journal:  Antibiotics (Basel)       Date:  2021-02-28

8.  Antimicrobial prescribing by Belgian dentists in ambulatory care, from 2010 to 2016.

Authors:  Thomas Struyf; Eline Vandael; Roos Leroy; Karl Mertens; Boudewijn Catry
Journal:  Int Dent J       Date:  2019-08-02       Impact factor: 2.607

9.  Antibiotic prescribing habits of dental surgeons in hyderabad city, India, for pulpal and periapical pathologies: a survey.

Authors:  K Pavan Kumar; Mamta Kaushik; P Udaya Kumar; M Shilpa Reddy; Neha Prashar
Journal:  Adv Pharmacol Sci       Date:  2013-09-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.